Fingerprint
Dive into the research topics of 'Trastuzumab: Molecularly targeted therapy for early and metastatic HER-2/neu-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Trastuzumab: Molecularly targeted therapy for early and metastatic HER-2/neu-positive breast cancer
Leisha A. Emens
Research output: Contribution to journal › Review article › peer-review